Iron overload: pathogenesis and treatment with chelating agents.
D001803:Blood Transfusion; D001815:Bloodletting; D002614:Chelating Agents / Q000627:therapeutic use*; D003676:Deferoxamine / Q000008:administration & dosage / Q000627:therapeutic use; D006432:Hemochromatosis / Q000378:metabolism* / Q000628:therapy; D006801:Humans; D007263:Infusions, Parenteral; D007408:Intestinal Absorption; D007501:Iron / Q000378:metabolism*; D013789:Thalassemia / Q000378:metabolism* / Q000628:therapy
D002614:Chelating Agents; D007501:Iron; D003676:Deferoxamine